Spectra Mdcl Devices Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SPECTRA MDCL DEVICES
SPECTRA MDCL DEVICES has two approved drugs.
Summary for Spectra Mdcl Devices
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Spectra Mdcl Devices
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spectra Mdcl Devices | SODIUM CHLORIDE 0.9% | sodium chloride | SOLUTION;INJECTION | 206171-002 | Jul 21, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Spectra Mdcl Devices | SODIUM CHLORIDE 0.9% | sodium chloride | SOLUTION;INJECTION | 206171-001 | Jul 21, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Spectra Mdcl Devices | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 208017-001 | Apr 18, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
